Latest Earnings Results: Q3 '26
Estimated EPS
$0.51
Reported EPS
$0.60
Surprise
+17.49%
Estimated Rev
$984.8M
Reported Rev
$988.6M
Surprise
+0.39%
• Reported GAAP EPS of $0.60 down -25.00% YoY • Reported revenue of $988.6M down -5.24% YoY • Perrigo's FY2026 All In outlook is net sales growth of (5.7)% to (4.6)%, adjusted gross margin 37.8% to 38.8%, adjusted operating margin 14.3% to 15.3%, and adjusted EPS $2.25 to $2.45.
Bullish Takeaway
Perrigo gained share in U.S. store brand OTC and key European brands, reported strong Womens Health growth, and expects the Infant Formula sale to simplify its portfolio and support reinvestment.
Bearish Takeaway
Perrigo reported lower consumption, more measured retailer inventory positioning and lower contract manufacturing volumes; adjusted margins and EPS declined, while competition and pricing pressures are identified risks.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $0.82 | -- | -- | N/A |
Q3 '26 | $0.51 | $0.60 | 17.49% | BEAT |
Q2 '26 | $0.34 | $0.50 | 47.06% | BEAT |
Q1 '26 | $0.31 | $0.43 | 40.16% | BEAT |
Q4 '25 | $0.78 | $0.77 | -1.76% | MISSED |